HYUNDAI BIOLAND Co.Ltd (KQ:052260) — Market Cap & Net Worth

$40.97 Million USD  · ₩60.45 Billion KRW  · Rank #22743

Market Cap & Net Worth: HYUNDAI BIOLAND Co.Ltd (052260)

HYUNDAI BIOLAND Co.Ltd (KQ:052260) has a market capitalization of $40.97 Million (₩60.45 Billion) as of September 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22743 globally and #1482 in its home market, demonstrating a 2.81% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying HYUNDAI BIOLAND Co.Ltd's stock price ₩4030.00 by its total outstanding shares 15000000 (15.00 Million). Also see 052260 current and non-current assets for a full breakdown of the balance sheet.

HYUNDAI BIOLAND Co.Ltd Market Cap History: 2015 to 2026

HYUNDAI BIOLAND Co.Ltd's market capitalization history from 2015 to 2026. Data shows change from $129.15 Million to $40.97 Million (-8.59% CAGR). Also see HYUNDAI BIOLAND Co.Ltd cash flow conversion for how efficiently the company converts equity into cash flow.

Index Memberships

HYUNDAI BIOLAND Co.Ltd is a constituent of 2 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
Kosdaq Composite Index
KOSDAQ
$234.31 Billion 0.02% #728 of 1384
Kosdaq Composite Index
KQ11
$234.31 Billion 0.02% #728 of 1384

Weight: HYUNDAI BIOLAND Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

HYUNDAI BIOLAND Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how HYUNDAI BIOLAND Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check HYUNDAI BIOLAND Co.Ltd stock price for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.00x

HYUNDAI BIOLAND Co.Ltd's market cap is 0.00 times its annual revenue

Industry average: 0.00x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.01x

HYUNDAI BIOLAND Co.Ltd's market cap is 0.01 times its annual earnings

Industry average: 0.01x Higher than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2015 $129.15 Million $80.90 Billion $10.79 Billion 0.00x 0.01x
2016 $85.01 Million $97.81 Billion $12.43 Billion 0.00x 0.01x
2017 $96.44 Million $102.56 Billion $11.98 Billion 0.00x 0.01x
2018 $77.59 Million $100.59 Billion $15.05 Billion 0.00x 0.01x
2019 $104.82 Million $106.31 Billion $10.85 Billion 0.00x 0.01x
2020 $122.26 Million $88.90 Billion -$13.55 Billion 0.00x N/A
2021 $86.36 Million $102.80 Billion -$11.69 Billion 0.00x N/A
2022 $67.88 Million $99.15 Billion $4.76 Billion 0.00x 0.01x
2023 $50.72 Million $96.72 Billion $8.06 Billion 0.00x 0.01x
2024 $45.90 Million $119.52 Billion $5.70 Billion 0.00x 0.01x

Competitor Companies of 052260 by Market Capitalization

Companies near HYUNDAI BIOLAND Co.Ltd in the global market cap rankings as of September 18, 2026. Review 052260 intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to HYUNDAI BIOLAND Co.Ltd by market ranking:

  • NeoPharm CO. LTD (KQ:092730): Ranked #18463 globally with a market cap of $124.25 Million USD ( ₩183.34 Billion KRW).
  • Globon Co. Ltd (KQ:019660): Ranked #23934 globally with a market cap of $29.52 Million USD ( ₩43.57 Billion KRW).
  • Gentrogroup Co. Ltd. (KQ:083660): Ranked #25130 globally with a market cap of $20.44 Million USD ( ₩30.15 Billion KRW).
  • Aether Holdings, Inc. (NASDAQ:ATHR): Ranked #22734 globally with a market cap of $41.02 Million USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#18463 NeoPharm CO. LTD KQ:092730 $124.25 Million ₩22950.00
#23934 Globon Co. Ltd KQ:019660 $29.52 Million ₩1498.00
#25130 Gentrogroup Co. Ltd. KQ:083660 $20.44 Million ₩1527.00
#22734 Aether Holdings, Inc. NASDAQ:ATHR $41.02 Million $3.39

HYUNDAI BIOLAND Co.Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, HYUNDAI BIOLAND Co.Ltd's market cap moved from $129.15 Million to $ 40.97 Million, with a yearly change of -8.59%.

Year Market Cap Change (%)
2026 ₩40.97 Million -6.17%
2025 ₩43.66 Million -4.87%
2024 ₩45.90 Million -9.52%
2023 ₩50.72 Million -25.27%
2022 ₩67.88 Million -21.40%
2021 ₩86.36 Million -29.36%
2020 ₩122.26 Million +16.63%
2019 ₩104.82 Million +35.10%
2018 ₩77.59 Million -19.55%
2017 ₩96.44 Million +13.44%
2016 ₩85.01 Million -34.17%
2015 ₩129.15 Million --

End of Day Market Cap According to Different Sources

On Sep 18th, 2026 the market cap of HYUNDAI BIOLAND Co.Ltd was reported to be:

Source Market Cap
Yahoo Finance $40.97 Million USD
MoneyControl $40.97 Million USD
MarketWatch $40.97 Million USD
marketcap.company $40.97 Million USD
Reuters $40.97 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About HYUNDAI BIOLAND Co.Ltd

KQ:052260 Korea Personal & Household Products & Services
Market Cap
$40.97 Million
₩60.45 Billion KRW
Market Cap Rank
#22743 Global
#1482 in Korea
Share Price
₩4030.00
Change (1 day)
+0.37%
52-Week Range
₩3225.00 - ₩5230.00
All Time High
₩21553.60
About

HYUNDAI BIOLAND Co.,Ltd manufactures and sells raw materials for cosmetics, nutraceuticals, and regenerative medicines. It offers anti-aging, moisturizing, whitening, skin protection, and other cosmetic ingredients; functional food ingredients and general food raw materials; and active pharmaceutical ingredients. The company was formerly known as SKbioland Co., Ltd. and changed its name to HYUNDA… Read more